Novo Nordisk GAAP EPADR of DKK 5.68, revenue of DKK 65.35B; updates FY24 outlook

Novo Nordisk GAAP EPADR of DKK 5.68, revenue of DKK 65.35B; updates FY24 outlook

SeekingAlpha

Published